Previous investigations have demonstrated that the upregulation of Nrf2/HO-1 reduces inflammation and plays a major role in anti-inflammatory function, suggesting that Nrf2 is a therapeutic target in inflammation-associated diseases (Ahmed et al. 2017). Here, NFE2L2 is linked to inflammation.